Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
Talha AnwarCelina G Kleer

Abstract

African and African-American (AA) women have higher incidence of triple-negative breast cancers (TNBC) with high histological grade and aggressive clinical behavior, but the reasons are not fully understood. We recently found that the oncogenic protein EZH2 is overexpressed in Ghanaian breast cancer patients, with 16% of the tumors expressing cytoplasmic EZH2. Understanding the molecular underpinnings of these aggressive tumors may lead to the identification of potential targetable oncogenic drivers. We characterized the copy number variations of 11 Ghanaian breast tumor patients by targeted multiplexed PCR-based DNA next-generation sequencing (NGS) over 130 cancer-relevant genes. While the DNA quality was not optimal for mutation analysis, 90% of the tumors had frequent recurrent copy number alterations (CNAs) of 17 genes: SDHC, RECQL4, TFE3, BCL11A, BCL2L1, PDGFRA, DEK, SMUG1, AKT3, SMARCA4, VHL, KLF6, CCNE1, G6PD, FGF3, ABL1, and CCND1, with the top oncogenic functions being mitotic G1-G1/S-phase regulation, gene transcription, apoptosis, and PI3K/AKT pathway. The most common recurrent high-level CNAs were gains of RECQL4 and SDHC, in 50% and 60% of cases, respectively. Network analyses revealed a significant predicted inter...Continue Reading

References

Oct 11, 2002·Nature·Sooryanarayana VaramballyArul M Chinnaiyan
Sep 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Celina G KleerArul M Chinnaiyan
Jan 6, 2005·The Oncologist·Lisa A Newman
Dec 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ingeborg M BachmannLars A Akslen
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yinghui GuanJoe W Gray
Feb 12, 2008·Nature Genetics·Rosalind A EelesDouglas F Easton
Aug 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dezheng HuoOlufunmilayo I Olopade
Sep 24, 2010·Molecular Endocrinology·Daniel J Toft, Vincent L Cryns
Jul 31, 2013·PloS One·Hongbo FangYongliang Zhao
Jun 3, 2014·Surgical Oncology Clinics of North America·Prasanna Alluri, Lisa A Newman
Jan 17, 2015·Molecular Cancer Research : MCR·Andi K CaniScott A Tomlins
Mar 6, 2015·Clinical and Experimental Pharmacology & Physiology·Muyang DingYane Gao
May 1, 2015·Neoplasia : an International Journal for Oncology Research·Daniel H HovelsonScott A Tomlins
Dec 23, 2015·The Journal of Pathology·Arvind AroraSrinivasan Madhusudan
Apr 1, 2017·BMC Cancer·Tuukka VeijaVirinder Kaur Sarhadi
Oct 27, 2017·Journal of Clinical Pathology·Alessandro Pietro Aldera, Dhirendra Govender
May 8, 2018·The Journal of Pathology·Jinfeng CaoMartine J Jager

❮ Previous
Next ❯

Citations

Dec 22, 2020·Frontiers in Genetics·Rosina De CarioElena Sticchi

❮ Previous
Next ❯

Methods Mentioned

BETA
chips

Software Mentioned

UALCAN
Torrent Suite
REACTOME
PANTHER

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.